drugset / Trial / NCT05124067

Effect of Dexmedetomidine on Prevention of Postoperative Nausea and Vomiting in Children

NCT05124067

Phase 1 Completed 4 enrolled Tanta University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

this study will aim to evaluate the effects of dexmedetomidine, dexamethasone and Ondansetron on the prevention of postoperative nausea and vomiting in children undergoing dental rehabilitation surgery.

Timeline

Start
2021-10-27
Primary completion
2022-01-30
Completion
2022-03-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.15 mg/kg Intravenous
Subject Dexmedetomidine Other / unclassified 0.3 ug/kg
Subject Ondansetron Other / unclassified 0.05 mg/kg Intravenous

Indications